Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study. Issue 1 (30th June 2020)
- Record Type:
- Journal Article
- Title:
- Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study. Issue 1 (30th June 2020)
- Main Title:
- Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
- Authors:
- Petersen, Melissa E.
Zhang, Fan
Schupf, Nicole
Krinsky‐McHale, Sharon J.
Hall, James
Mapstone, Mark
Cheema, Amrita
Silverman, Wayne
Lott, Ira
Rafii, Michael S.
Handen, Benjamin
Klunk, William
Head, Elizabeth
Christian, Brad
Foroud, Tatiana
Lai, Florence
Rosas, H. Diana
Zaman, Shahid
Ances, Beau M.
Wang, Mei‐Cheng
Tycko, Benjamin
Lee, Joseph H.
O'Bryant, Sid - Abstract:
- Abstract: Introduction: Previously generated serum and plasma proteomic profiles were examined among adults with Down syndrome (DS) to determine whether these profiles could discriminate those with mild cognitive impairment (MCI‐DS) and Alzheimer's disease (DS‐AD) from those cognitively stable (CS). Methods: Data were analyzed on n = 305 (n = 225 CS; n = 44 MCI‐DS; n = 36 DS‐AD) enrolled in the Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS). Results: Distinguishing MCI‐DS from CS, the serum profile produced an area under the curve (AUC) = 0.95 (sensitivity [SN] = 0.91; specificity [SP] = 0.99) and an AUC = 0.98 (SN = 0.96; SP = 0.97) for plasma when using an optimized cut‐off score. Distinguishing DS‐AD from CS, the serum profile produced an AUC = 0.93 (SN = 0.81; SP = 0.99) and an AUC = 0.95 (SN = 0.86; SP = 1.0) for plasma when using an optimized cut‐off score. AUC remained unchanged to slightly improved when age and sex were included. Eotaxin3, interleukin (IL)‐10, C‐reactive protein, IL‐18, serum amyloid A, and FABP3 correlated fractions at r 2 > = 0.90. Discussion: Proteomic profiles showed excellent detection accuracy for MCI‐DS and DS‐AD.
- Is Part Of:
- Alzheimer's & dementia. Volume 12:Issue 1(2020)
- Journal:
- Alzheimer's & dementia
- Issue:
- Volume 12:Issue 1(2020)
- Issue Display:
- Volume 12, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 12
- Issue:
- 1
- Issue Sort Value:
- 2020-0012-0001-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2020-06-30
- Subjects:
- Alzheimer's disease -- Periodicals
Alzheimer's disease -- Diagnosis -- Periodicals
Dementia -- Periodicals
Dementia -- Diagnosis -- Periodicals
616.831 - Journal URLs:
- https://alz-journals.onlinelibrary.wiley.com/loi/23528729 ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1002/dad2.12039 ↗
- Languages:
- English
- ISSNs:
- 2352-8729
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25848.xml